A Phase I/II Clinical Study of Topical Minoxidil in Acne Vulgaris

Status: Unknown
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1/Phase 2
SUMMARY

Objectives: primary: to test the toxicity of topical minoxidil in treatment of acne vulgaris; second: to evaluate the response and disease control rate in this pilot study. Measurement: Time to resolution of individual acne lesions (14 days) Monitor of treatment efficacy: number of inflammatory acne lesions counting, time to resolution of individual acne lesion, and degree of acne severity measurement.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 50
Healthy Volunteers: f
View:

• Gender: both

• Age limit: 20\

⁃ 50 year/old

• Acne vulgaris: mild to moderate degree (Investigator's Global Assessment Scale:2\

Locations
Other Locations
Taiwan
Linkou Chang Gung Memorial Hospital
RECRUITING
Taoyuan District
Contact Information
Primary
Cheng-Lung Hsu, Profesor
hsu2221@cgmh.org.tw
(886)33281200
Backup
He-Cing Fan
r94b47405@cgmh.org.tw
(886)33281200
Time Frame
Start Date: 2023-07-11
Completion Date: 2023-12-31
Participants
Target number of participants: 26
Treatments
Experimental: topical minoxidil in Acne Vulgaris
Split face: 2% or 5% topical minoxidil solution applied and no treatment Description: Subjects will apply the 2% or 5% topical minoxidil solution to every inflammatory acne facial lesion on one half of the face and no treatment to every inflammatory acne lesion on the other half of the face twice a day for 4 weeks.
Related Therapeutic Areas
Sponsors
Leads: Chang Gung Memorial Hospital

This content was sourced from clinicaltrials.gov